The CNS is a sanctuary and reservoir for HIV, which is known to enter the CNS within days of primary infection. We sought to assess whether early ART would improve neurocognitive performance (NP) in the Sabes study, a cohort of men who have sex with men (MSM) and transgender women (TW) in Lima, Peru randomized to start ART at diagnosis (within 30-90 days of estimated date of detectable infection (EDDI)) vs. after a short delay. We hypothesized that, by limiting CNS infection, ART initiation within 30 days of HIV acquisition would improve NP compared to ART initiation later in early infection.
A subset of Sabes participants had neurocognitive assessments and blood collection, and in some cases, lumbar puncture. NP was measured with a 15-test battery covering Gross motor, Attention, Executive, Learning, Memory, Speed of Processing, and Fine Motor domains at weeks 12, 24, 48, 72, 96 and 120 after randomization. Estimated date of infection (EDDI) was derived from an algorithm compiling test parameters of last negative and first positive HIV tests.
The 112 participants were all hispanic MSM or TW, had a mean age of 26.4 years (SD=7.4), mean education grade level of 12.5 (SD=2.3) and mean baseline CD4+ cell count of 443.4 (SD=210.4). Seventy-seven observations came from participants with an EDDI to ART initiation interval of <30 days, 190 from participants who started ART after 31-90 days, and 262 from those who started ART 91 to 249 days after EDDI (>90 days). NP did not differ significantly between the EDDI to ART categories over time (mean total z for <30 = .42, 31-90= .39, >90=.32; p=ns). However, NP significantly improved with ART out to 120 weeks of follow up (F=(5, 394)=35.9, p<.0001), across categories (mean total z score at week 0=0.09, week 12=0.28, week 24=0.41, week 48=0.47, week 72 = 0.50, week 96=0.52). As a check for practice effects, gait (resistant to practice) was significantly improved over time (F(5.391)=2.94, p<.05), indicating that ART had a substantial impact on NP.
In this unique early infection cohort, time between primary infection and ART initiation was not associated with neurocognition. Initiation of ART improved neurocognitive functioning regardless of treatment category: this cohort of persons who started ART during or just following acute infection had improved cognitive performance as time on ART increased. These findings underscore the importance of initiating ART early to protect the CNS.